Hemp-Derived Consumables/Controlled Substance Changes.

This bill amends the composition of North Carolina's Medical Cannabis Production Commission to ensure a more diverse range of oversight. It establishes a 13-member body that includes representatives from law enforcement, agriculture, pharmacy, and medicine, alongside industry experts and patient advocates. A specific provision requires industry representatives to recuse themselves from license selection decisions if they have a personal or business connection to an applicant. The amendment also sets new term lengths and expiration dates for these commissioners to structure their service periods.